MedTrace Logo

A Clinical Evaluation of Two Contact Lenses Used With Three Care Systems

NCT04195581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2021-06-11

Study results available
· View outcomes & findings →

Summary

The objective of the study was to compare the clinical performance of the two contact lenses when used in combination with three care systems.

Conditions

  • Myopia

Interventions

DEVICE

comfilcon A

Subjects were randomized to wear each lens and solution combination for a month.

DEVICE

fanfilcon A

Subjects were randomized to wear each lens and solution combination for a month.

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Philip Morgan, MCOptom FAAO FBCLA · Eurolens Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-16
Primary Completion
2020-05-07
Completion
2020-05-07
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04195581 on ClinicalTrials.gov